The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...
This article was originally published here
J Diabetes Sci Technol. 2021, April 15: 19322968211006476. doi: 10.1177 / 19322968211006476. Online before printing.
ABSTRACT
BACKGROUND: The use of...